BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1527728)

  • 1. Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass.
    Zalups RK; Gelein RM; Cherian MG
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1256-66. PubMed ID: 1527728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMPS as a rescue agent for the nephropathy induced by mercuric chloride.
    Zalups RK; Gelein RM; Cernichiari E
    J Pharmacol Exp Ther; 1991 Jan; 256(1):1-10. PubMed ID: 1671092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of different degrees of reduced renal mass on the renal and hepatic disposition of administered cadmium.
    Zalups RK
    J Toxicol Environ Health; 1997 Jun; 51(3):245-64. PubMed ID: 9183381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
    Zalups RK
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):121-31. PubMed ID: 7839359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal metallothionein metabolism after a reduction of renal mass. II. Effect of zinc pretreatment on the renal toxicity and intrarenal accumulation of inorganic mercury.
    Zalups RK; Cherian MG
    Toxicology; 1992; 71(1-2):103-17. PubMed ID: 1729759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotoxicity of repeated injections of cadmium-metallothionein in rats.
    Wang XP; Chan HM; Goyer RA; Cherian MG
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):11-6. PubMed ID: 8470114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
    Zalups RK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cadmium-Metallothionein nephropathy: relationships between ultrastructural/biochemical alterations and intracellular cadmium binding.
    Squibb KS; Pritchard JB; Fowler BA
    J Pharmacol Exp Ther; 1984 Apr; 229(1):311-21. PubMed ID: 6707945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mercuric chloride-induced cytotoxicity and compensatory hypertrophy in rat kidney proximal tubular cells.
    Lash LH; Zalups RK
    J Pharmacol Exp Ther; 1992 May; 261(2):819-29. PubMed ID: 1578387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nephrotoxicity of intravenously administered cadmium-metallothionein: effect of dose, mode of administration, and preexisting renal cadmium burden.
    Vestergaard P; Shaikh ZA
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):240-7. PubMed ID: 8209377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chlorpromazine pretreatment on cadmium toxicity in the male Wistar (WF/NCr) rat.
    Shiraishi N; Rehm S; Waalkes MP
    J Toxicol Environ Health; 1994 Jun; 42(2):193-208. PubMed ID: 8207755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal toxicity of cadmium-metallothionein and enzymuria in rats.
    Suzuki CA; Cherian MG
    J Pharmacol Exp Ther; 1987 Jan; 240(1):314-9. PubMed ID: 2879904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
    Min KS; Onosaka S; Tanaka K
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
    Dorian C; Gattone VH; Klaassen CD
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of parameters of cadmium exposure with onset of cadmium-induced nephropathy in rats.
    Goyer RA; Cherian MG; Delaquerriere-Richardson L
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):89-100. PubMed ID: 6520742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative toxicity of cadmium-metallothionein and cadmium chloride on mouse kidney.
    Nordberg GF; Goyer R; Nordberg M
    Arch Pathol; 1975 Apr; 99(4):192-7. PubMed ID: 1115684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of nephrotoxicity induced by repeated administration of cadmium chloride in rats.
    Sudo J; Hayashi T; Kimura S; Kakuno K; Terui J; Takashima K; Soyama M
    J Toxicol Environ Health; 1996 Jul; 48(4):333-48. PubMed ID: 8691505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.